$NWBO
Let's look at news in the UK, that explicitly have pointed out the parent/child relationship of NWBO and the CDMO Advent Bioservices, situated on the same compound within the same building at Sawston, Cambridge, UK.
cambridgeindependent.co.uk/business/sawst…
Let's look at news in the UK, that explicitly have pointed out the parent/child relationship of NWBO and the CDMO Advent Bioservices, situated on the same compound within the same building at Sawston, Cambridge, UK.
cambridgeindependent.co.uk/business/sawst…
1 )
"Linda Powers, CEO of Northwest Biotherapeutics (NW Bio), has paid tribute to the clinical development team at Sawston Business Park – and contractor Advent BioServices"
"Linda Powers, CEO of Northwest Biotherapeutics (NW Bio), has paid tribute to the clinical development team at Sawston Business Park – and contractor Advent BioServices"
2)
"The Maryland-based biotechnology company has been developing personalised immunotherapy products designed to treat solid tumour cancers, with input from its R&D team at Sawston"
"The Maryland-based biotechnology company has been developing personalised immunotherapy products designed to treat solid tumour cancers, with input from its R&D team at Sawston"
3)
"Production of the first NW Bio dendritic cell cancer vaccine for a compassionate use patient at the licensed production facility in Sawston"
4)
"That Northwest Biotherapeutics, together with our contractor Advent BioServices..."
"Production of the first NW Bio dendritic cell cancer vaccine for a compassionate use patient at the licensed production facility in Sawston"
4)
"That Northwest Biotherapeutics, together with our contractor Advent BioServices..."
5)
"NW Bio plans to continue developing the Sawston facility in phases..."
"NW Bio plans to continue developing the Sawston facility in phases..."
cambridgeindependent.co.uk/business/adven…
6)
"Northwest Biotherapeutics has secured MHRA certification for its cancer vaccine trials in the Sawston Business Park, sparking delight for site developer Advent BioServices."
6)
"Northwest Biotherapeutics has secured MHRA certification for its cancer vaccine trials in the Sawston Business Park, sparking delight for site developer Advent BioServices."
7)
"Advent, which is based on the Park, has completed the laboratory facilities to UK regulatory standards on behalf of Northwest Biotherapeutics..."
8)
"NW Bio’s Sawston R&D team is working on a cancer vaccine for glioblastoma multiforme..."
"Advent, which is based on the Park, has completed the laboratory facilities to UK regulatory standards on behalf of Northwest Biotherapeutics..."
8)
"NW Bio’s Sawston R&D team is working on a cancer vaccine for glioblastoma multiforme..."
9)
"Last month, the company’s (NWBO) state-of-the-art manufacturing facility on Sawston Business Park received MHRA approval for the manufacture..."
"Last month, the company’s (NWBO) state-of-the-art manufacturing facility on Sawston Business Park received MHRA approval for the manufacture..."
10)
"Advent BioServices began as a cell therapy contract development and manufacturing organisation (CDMO) in 2016. Currently there are 40 staff working on the site, of whom about 40 per cent are scientists."
"Advent BioServices began as a cell therapy contract development and manufacturing organisation (CDMO) in 2016. Currently there are 40 staff working on the site, of whom about 40 per cent are scientists."
11)
"Dr Mike Scott, who joined Advent as COO in April 2019, has overseen the design."
“Advent was contracted to build out the facility in 2019..."
"Dr Mike Scott, who joined Advent as COO in April 2019, has overseen the design."
“Advent was contracted to build out the facility in 2019..."
12)
"The MHRA manufacturing approval is connected to the site at Sawston Business Park,” Mike says, “and Advent is contracted to put together everything for that licensing, which was granted in mid-December."
"The MHRA manufacturing approval is connected to the site at Sawston Business Park,” Mike says, “and Advent is contracted to put together everything for that licensing, which was granted in mid-December."
13) 
businessweekly.co.uk/news/biomedtec…
14)
"A US company personalising immune therapies for solid tumour cancers has raised further money to complete the Phase 1 buildout of a UK manufacturing facility in Sawston, Cambridge"
14)
"A US company personalising immune therapies for solid tumour cancers has raised further money to complete the Phase 1 buildout of a UK manufacturing facility in Sawston, Cambridge"
businessweekly.co.uk/news/biomedtec…
15)
"Northwest Biotherapeutics, a Maryland-based company developing personalised cancer vaccines, has finished initial buildout of a plant in Sawston, Cambridge which it intends to be a centre of excellence for manufacturing advanced therapies."
15)
"Northwest Biotherapeutics, a Maryland-based company developing personalised cancer vaccines, has finished initial buildout of a plant in Sawston, Cambridge which it intends to be a centre of excellence for manufacturing advanced therapies."
16)
"The primary goal is to prepare for production of Northwest Biotherapeutics’ lead candidate, DCVax-L, the first medicine to be awarded the UK’s ‘Promising Innovative Medicine’ (PIM) designation"
"The primary goal is to prepare for production of Northwest Biotherapeutics’ lead candidate, DCVax-L, the first medicine to be awarded the UK’s ‘Promising Innovative Medicine’ (PIM) designation"
businessweekly.co.uk/news/biomedtec…
17)
"US cancer technology company Northwest Biotherapeutics is hopeful of rolling out transformational product from its new Cambridge UK facility in Q3 of this year."
17)
"US cancer technology company Northwest Biotherapeutics is hopeful of rolling out transformational product from its new Cambridge UK facility in Q3 of this year."
18)
"...development of a Cambridge team of nearly 40 people with all of the required types of expertise for production of Advanced Therapy Medicinal Products and training in regard to the DCVax® technology and processes".
"...development of a Cambridge team of nearly 40 people with all of the required types of expertise for production of Advanced Therapy Medicinal Products and training in regard to the DCVax® technology and processes".
businessweekly.co.uk/tech-trail/tec…
19)
"COO Dr Mike Scott, who previously enjoyed 28 years with Cambridge University Hospitals, says the Sawston hothouse – run by Advent BioServices under a service contract for US-based Northwest Biotherapeutics which owns the long-term facility lease..."
19)
"COO Dr Mike Scott, who previously enjoyed 28 years with Cambridge University Hospitals, says the Sawston hothouse – run by Advent BioServices under a service contract for US-based Northwest Biotherapeutics which owns the long-term facility lease..."
20)
"Its various laboratories, GMP clean rooms, cold room storage – to cryostorage temperatures – and biobank are already being used to good effect by Advent on behalf of NW Bio and various external clients – and the partners haven’t even started any external marketing as yet."
"Its various laboratories, GMP clean rooms, cold room storage – to cryostorage temperatures – and biobank are already being used to good effect by Advent on behalf of NW Bio and various external clients – and the partners haven’t even started any external marketing as yet."
21)
"Advent and NW Bio, who are developing the facility were buoyed and are already exploiting the recent award of specialist manufacturing and tissue handling approvals that should boost demand and productivity."
"Advent and NW Bio, who are developing the facility were buoyed and are already exploiting the recent award of specialist manufacturing and tissue handling approvals that should boost demand and productivity."
22)
"The transatlantic owners of the facility anticipate..."
23)
"To maximise overall potential capacity of the Sawston facility, Advent is actively recruiting third party clients interested in production of bespoke and personalised cell therapy products."
"The transatlantic owners of the facility anticipate..."
23)
"To maximise overall potential capacity of the Sawston facility, Advent is actively recruiting third party clients interested in production of bespoke and personalised cell therapy products."
24)
"The capacity for production of other products will also be an important resource for the region, helping to fulfil NWBio’s commitments to the Cambridgeshire and Peterborough Development Authority."
"The capacity for production of other products will also be an important resource for the region, helping to fulfil NWBio’s commitments to the Cambridgeshire and Peterborough Development Authority."
25)
"Scott has identified from major players in the Bio industry that there is huge and growing international demand for exactly the type and variety of facilities Advent and NW Bio can supply – over and above the manufacture of their own product portfolio. "
"Scott has identified from major players in the Bio industry that there is huge and growing international demand for exactly the type and variety of facilities Advent and NW Bio can supply – over and above the manufacture of their own product portfolio. "
26)
"It is clearly a very good space for us to be in as market demand accelerates globally,” Scott remarks. “It is an exciting time for Advent BioServices and NW Bio and validates the decision to build and expand the Sawston facility.”
"It is clearly a very good space for us to be in as market demand accelerates globally,” Scott remarks. “It is an exciting time for Advent BioServices and NW Bio and validates the decision to build and expand the Sawston facility.”
businessweekly.co.uk/news/biomedtec…
27)
"Business Weekly reported in early February that production was set to get underway at the company’s Sawston facility."
27)
"Business Weekly reported in early February that production was set to get underway at the company’s Sawston facility."
28)
"Since the licence was issued, Advent Bioservices – NW Bio’s contract manufacturer in the UK..."
"Since the licence was issued, Advent Bioservices – NW Bio’s contract manufacturer in the UK..."
29)
"NW Bio plans to continue developing the Sawston facility in phases, both to calibrate the capital expenditures with the capacity needed and to leave room for implementation of new technologies. "
"NW Bio plans to continue developing the Sawston facility in phases, both to calibrate the capital expenditures with the capacity needed and to leave room for implementation of new technologies. "
• • •
Missing some Tweet in this thread? You can try to
force a refresh
